OSCR

Mitochondrial protein alterations in vascular dementia: evidence from Mendelian randomization, transcriptomics, and a chronic hypoperfusion model.

Overview

Authors: Qian Liu1,2, Huizhong Tan2, Keke Tong1, Ruhai Luo1, Hanquan Li1, Feng Qiu3, Shiliang Wang2, Le Xie2, Xiuli Zhang3, Dahua Wu2
  1. Graduate School of Hunan University of Chinese Medicine, Changsha, Hunan, China
  2. Department of Neurology, Hunan Hospital of Integrated Traditional Chinese and Western Medicine, Changsha, Hunan, China
  3. Institute of Innovation and Applied Research, Hunan University of Chinese Medicine, Changsha, Hunan, China
Journal: Frontiers in neurology, volume 17, article 1794851
Dates: received 23 January 2026; accepted 24 June 2026; published online 9 July 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.3389/fneur.2026.1794851 · PMID 42494396 · PMCID PMC13391407 · OpenAlex W7167810257
Open access: gold, a free copy (OpenAlex)
Categories: genetics / omics (modality), rat (organism), Alzheimer's / dementia (population), stroke (population), cellular / molecular (subfield)
Methods: Statistics, Spectral & time-frequency
Keywords: bioinformatics, Gene Expression Omnibus, analysis, Mendelian randomization, mitochondrial dysfunction, vascular dementia
Topic: Neurological Disease Mechanisms and Treatments (Neurology, Neuroscience), according to OpenAlex
Citations: not cited yet (Europe PMC); 31 references in the paper

Abstract

Objective: Mitochondrial dysfunction is a key pathological feature of vascular dementia (VaD), yet the specific systemic and localized proteins involved remain unclear. We aim to utilize Mendelian randomization (MR) of plasma proteomics and Gene Expression Omnibus (GEO) datasets to identify systemic circulating biomarkers associated with VaD risk, and subsequently use in vivo models to investigate whether these systemic signals correspond to actual neuropathological mitochondrial changes in the brain.

Methods: We first identified candidate proteins associated with VaD risk through a two-sample MR analysis of plasma proteomics and GWAS data. Candidate genes were then assessed for differential expression using the GEO dataset GSE122063. Finally, the proteins were validated in a Bilateral Common Carotid Artery Occlusion (2-VO) rat model by evaluating pathological features and measuring its expression levels via Western Blot.

Results: Mendelian randomization analysis identified four proteins nominally linked to VaD: protective factors (AIFM1, COX5B) and risk factors (NDUFV2, NUDT5). However, cross-referencing these genetic predictions with GEO transcriptomics (GSE122063) and a 2-VO rat model revealed distinct tiers of evidentiary support. COX5B emerged as the most robust targets, demonstrating unidirectional consistency across all three analytical layers. NUDT5 showed partial consistency, supported by genetic and animal data, though its transcriptomic alteration fell short of the threshold. Conversely, AIFM1 and NDUFV2 displayed clear directional contradictions between the genetic/transcriptomic data and actual in vivo protein expression. Notably, while donepezil improved VaD pathology, it did not alter the expression of these proteins.

Conclusion: Rather than universally validating all four genetic candidates, this rigorous multi-layer triangulation specifically pinpoints the dysregulation of COX5B as high-confidence, consistent drivers of mitochondrial impairment in VaD. Acknowledging the inconsistent complexities of AIFM1, NDUFV2, and NUDT5. Therapeutic strategies targeting the cleanly triangulated protein offer a more reliable, disease-modifying approach for VaD intervention.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data availability statement

The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/Supplementary material.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, pages, dates, 10 authors, 6 keywords, 31 references.

Cite

This paper

Liu, Q., Tan, H., Tong, K., Luo, R., Li, H., Qiu, F., Wang, S., Xie, L., Zhang, X., & Wu, D. (2026). Mitochondrial protein alterations in vascular dementia: evidence from Mendelian randomization, transcriptomics, and a chronic hypoperfusion model. Frontiers in neurology, 17, 1794851. https://doi.org/10.3389/fneur.2026.1794851

BibTeX

@article{liu2026mitochondrial,
author = {Liu, Qian and Tan, Huizhong and Tong, Keke and Luo, Ruhai and Li, Hanquan and Qiu, Feng and Wang, Shiliang and Xie, Le and Zhang, Xiuli and Wu, Dahua},
title = {{Mitochondrial protein alterations in vascular dementia: evidence from Mendelian randomization, transcriptomics, and a chronic hypoperfusion model}},
journal = {Frontiers in neurology},
year = {2026},
month = jul,
volume = {17},
pages = {1794851},
publisher = {Frontiers Media SA},
issn = {1664-2295},
doi = {10.3389/fneur.2026.1794851},
url = {https://doi.org/10.3389/fneur.2026.1794851},
pmid = {42494396},
pmcid = {PMC13391407}
}

RIS

TY - JOUR
AU - Liu, Qian
AU - Tan, Huizhong
AU - Tong, Keke
AU - Luo, Ruhai
AU - Li, Hanquan
AU - Qiu, Feng
AU - Wang, Shiliang
AU - Xie, Le
AU - Zhang, Xiuli
AU - Wu, Dahua
TI - Mitochondrial protein alterations in vascular dementia: evidence from Mendelian randomization, transcriptomics, and a chronic hypoperfusion model
T2 - Frontiers in neurology
J2 - Front Neurol
PY - 2026
DA - 2026/07/09
VL - 17
SP - 1794851
SN - 1664-2295
PB - Frontiers Media SA
DO - 10.3389/fneur.2026.1794851
UR - https://doi.org/10.3389/fneur.2026.1794851
LA - en
ER -

CSL-JSON

{
"id": "10.3389/fneur.2026.1794851",
"type": "article-journal",
"title": "Mitochondrial protein alterations in vascular dementia: evidence from Mendelian randomization, transcriptomics, and a chronic hypoperfusion model",
"container-title": "Frontiers in neurology",
"author": [
{
"family": "Liu",
"given": "Qian"
},
{
"family": "Tan",
"given": "Huizhong"
},
{
"family": "Tong",
"given": "Keke"
},
{
"family": "Luo",
"given": "Ruhai"
},
{
"family": "Li",
"given": "Hanquan"
},
{
"family": "Qiu",
"given": "Feng"
},
{
"family": "Wang",
"given": "Shiliang"
},
{
"family": "Xie",
"given": "Le"
},
{
"family": "Zhang",
"given": "Xiuli"
},
{
"family": "Wu",
"given": "Dahua"
}
],
"container-title-short": "Front Neurol",
"volume": "17",
"page": "1794851",
"DOI": "10.3389/fneur.2026.1794851",
"PMID": "42494396",
"PMCID": "PMC13391407",
"ISSN": "1664-2295",
"publisher": "Frontiers Media SA",
"URL": "https://doi.org/10.3389/fneur.2026.1794851",
"language": "en",
"issued": {
"date-parts": [
[
2026,
7,
9
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1186/s12931-024-03086-5
Potential drug targets for asthma identified through mendelian randomization analysis.
Journal: Respiratory research
In common: genetics / omics, 6 references
[2] doi:10.3389/fnmol.2022.751044
Identification of Molecular Signatures and Candidate Drugs in Vascular Dementia by Bioinformatics Analyses.
Journal: Frontiers in molecular neuroscience
In common: NCBI GEO GSE122063, stroke, Alzheimer's / dementia, cellular / molecular, 2 references
[3] doi:10.1002/brb3.71366
Integrative Multi-Omics Mendelian Randomization Highlights Causal Autophagy-Related Genes for Amyotrophic Lateral Sclerosis.
Journal: Brain and behavior
In common: genetics / omics, cellular / molecular, 5 references
[4] doi:10.1177/25424823241289804
Identifying shared diagnostic genes and mechanisms in vascular dementia and Alzheimer's disease via bioinformatics and machine learning.
Journal: Journal of Alzheimer's disease reports
In common: NCBI GEO GSE122063, stroke, Alzheimer's / dementia, cellular / molecular, 1 reference
[5] doi:10.1080/21655979.2021.1999553
Analysis of immune-related key genes in Alzheimer's disease.
Journal: Bioengineered
In common: NCBI GEO GSE122063, rat, Alzheimer's / dementia, genetics / omics, 1 other category, 1 reference
[6] doi:10.3233/adr-240062
Genome-Wide Mendelian Randomization Identifies Ferroptosis-Related Drug Targets for Alzheimer's Disease.
Journal: Journal of Alzheimer's disease reports
In common: NCBI GEO GSE122063, Alzheimer's / dementia, genetics / omics, cellular / molecular, 1 reference
[7] doi:10.1038/s41514-025-00228-x
Dysregulations of C1QA, C1QB, C1QC and C5AR1 as candidate biomarkers of vascular dementia.
Journal: npj aging
In common: NCBI GEO GSE122063, stroke, Alzheimer's / dementia, 1 reference
[8] doi:10.1038/s41598-026-40339-3
ELK1 suppressed the progression of vascular dementia via modulating mTOR/CREB/YAP/TFEB signaling induced ferroptosis in hippocampal cells.
Journal: Scientific reports
In common: NCBI GEO GSE122063, stroke, rat, Alzheimer's / dementia, 1 other category
[9] doi:10.3389/fgene.2022.1038585
Transcriptome analysis reveals potential marker genes for diagnosis of Alzheimer's disease and vascular dementia.
Journal: Frontiers in genetics
In common: NCBI GEO GSE122063, stroke, Alzheimer's / dementia, genetics / omics
[10] doi:10.1038/s41467-022-30184-z [code]
Genetic analyses identify pleiotropy and causality for blood proteins and highlight Wnt/β-catenin signalling in migraine.
Journal: Nature communications
In common: genetics / omics, cellular / molecular, 3 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.